跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 1,510 条关于
“Vesper Biotechnologies”
全部
1,510
临床试验
982
药物
196
机构
54
资讯
278
上个月
Brazil Rises to 2nd Worldwide in Clinical Trial Recruitment, Driven by Execution and Population Diversity
2年前
Vesper Bio's VES001 Shows Promise in Phase I Trial for Frontotemporal Dementia
去年
VESPER Trial: BaSq Subtype Linked to Poorer Outcomes in Bladder Cancer
去年
Vesper Bio's VES001 Shows Promise in Phase 1 Trial for Frontotemporal Dementia
去年
Vesper Bio Initiates Phase Ib/IIa Trial of VES001 for Frontotemporal Dementia (FTD) with GRN Mutations
10个月前
Vesper Bio's VES001 Shows 95% Increase in Progranulin Levels in Phase Ib/IIa Trial for Frontotemporal Degeneration
去年
Momentum Biotechnologies Acquires OmicScouts to Expand Mass Spectrometry-Based Drug Discovery Platform
去年
CollPlant Advances Regenerative Breast Implant Technology with Promising Preclinical Results
去年
Argenx Expands Partnership with Fujifilm Biotechnologies to Manufacture Efgartigimod in the U.S.
去年
Adverum's Ixo-vec Shows Promise in Wet AMD Phase 2 Trial, Phase 3 Planned for 2025
第 1 页,共 28 页
上一页
下一页